Download an outreach toolkit for World Sight Day

Article

Glaucoma patient and director of the movie Going Blind, Joe Lovett and his team have developed a comprehensive Outreach Toolkit with details on how doctors can use the film to raise awareness of funding, educate students and patients or promote themselves.

Glaucoma patient and director of the movie Going Blind, Joe Lovett and his team have developed a comprehensive Outreach Toolkit with details on how doctors can use the film to raise awareness of funding, educate students and patients or promote themselves.

Download the Outreach Toolkit here.

Ophthalmology Times Europe editor, Pamela Brook, said: “Joe's film is a patient’s story and a real insight into what the ophthalmology community can do to help. I would highly recommend it. Joe was diagnosed with blindness around 22 years ago and since then has been progressively losing his vision. Six years ago he decided to make a film to document the impact that blindness had on people’s lives and to relay his own experience in living with the condition. His film really does provide surgeons with a tool for their own patient education initiatives.”

The film can be ordered on DVD at www.goingblindmovie.com

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.